multiple sclerosis

Researchers created a new high-throughput tool to hunt for therapies that remyelinate the nervous system.

Experts say new research provides strong evidence that a common herpesvirus can trigger the chronic inflammatory disease.

Researchers found that lowering the temperature alleviates autoimmunity in mice.

Authors of a new review urge researchers to consider how the chromosomal sex of a cell affects experiments in research on neurodegeneration.

A study of 16,000 people suggests that human herpesvirus 6A is a risk factor for developing multiple sclerosis, reinvigorating a neglected hypothesis that the virus could be involved in triggering the disease.

Many dominant T cell variants decline during pregnancy and reappear afterward, possibly explaining why relapses of the autoimmune disease are less common when women are expecting.

Several early-stage clinical trials indicate that implanting patients with the cells is safe. But whether they can alleviate neurological problems remains to be seen.

A Chicago-based center that has long operated a clinical trial program for stem cell therapies, has stopped recruiting further patients as its chief, Richard Burt, leaves for a research sabbatical.

Molecules produced by resident bacteria and their hosts may signal immune cells to attack the body’s own tissues.

A neurologist by training, Stefánsson founded Iceland-based deCODE Genetics to explore what the human genome can tell us about disease and our species’ evolution.

Human endogenous retroviruses that colonized vertebrate DNA millions of years ago have long been dismissed as junk DNA, but researchers now know that they may play important roles in cancer, neurodegeneration, and other ailments.

Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.

In children’s brain scans, scientists uncovered signs of multiple sclerosis before the kids showed any symptoms of the disease.

Neuropsychologist Simon Thompson found a possible link between yawning and multiple sclerosis. So what better way to get under the skin of his research than volunteering to take part in one of his experiments?

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

Researchers identify a subset of proinflammatory cytokine-producing B cells that may spark multiple sclerosis-related inflammation.